MedTrace Logo

A Clinical Trial to Investigate the Efficacy and Safety of Tongkat Ali Maca Plus

NCT05347329 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 197

Last updated 2022-05-03

No results posted yet for this study

Summary

This was a randomized, double blind, placebo-controlled, Three-arm, multicenter, parallel groups, interventional phase II clinical trial evaluating the efficacy, and safety of a herbal medicinal product of dried roots of Eurycoma longifolia Jack (Tongkat Ali) and dried tuberous roots of Lepidium meyenii (Maca) for the improvement of sexual well-being and quality of life in men.

Conditions

Interventions

DIETARY_SUPPLEMENT

Tongkat Ali Maca Plus

Tongkat Ali and Maca (Tongkat Ali: powdered extract 200 mg (from roots of Eurycoma longifolia Jack) + Maca: powdered extract 100 mg (from dried tuberous root of Lepidium meyenii).

Sponsors & Collaborators

  • Natural Wellness Egypt

    lead INDUSTRY

Principal Investigators

  • Prof Dr. Mohamed badreldin, MD · Menoufia University/ Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-10
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05347329 on ClinicalTrials.gov